| GlaxoSmithKline AG - Zentel, Suspension zum Einnehmen | | 49749 | | 03 | | Zentel | | Suspension zum Einnehmen | | P02CA03 | | Albendazol | | 28.12.1993 | | |
| | Composition | | albendazolum 400 mg, magnesii aluminii silicas, carmellosum natricum, glycerolum (85 per centum), polysorbatum 80, sorbitani lauras, simeticonum, polysorbatum 65, methylcellulosum, macrogoli stearas, glyceroli monostearas 40-55, xanthani gummi, acidum sulfuricum, saccharinum natricum, aromatica Vanille cum alcohol benzylicus 2.2 mg et propylenglycolum 3.8 mg, aromatica Orangen, aromatica Passionsfrucht, E 200, E 202, E 210 20 mg, aqua purificata q.s. ad suspensionem pro 10 ml corresp. natrium 4.2 mg. | | Packungsbestandteile | | Suspension (orale) | | | | | | Principe actif | Concentr. |
|---|
| Albendazole | 400mg / 10ml |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Sulfurique | | | | Aqua Purificata | | | | Aromatica (Orangen) | | | | Aromatica (Vanille) cum Alcohol Benzylicus | 2.2mg / 10ml | | | Aromatica Passionsfrucht | | | | Carmellose Sodique | | | | E 200 | | conserv. | | E 202 | | conserv. | | E 210 | 20mg / 10ml | conserv. | | Glyceroli Monostearas | 40-55 | | | Glycerol | | | | Macrogoli Stearas | | | | Magnesii Aluminii Silicas | | | | Methylcellulosum | | | | Polysorbatum 65 | | | | Polysorbatum 80 | | | | Propylenglycol | 3.8mg / 10ml | | | Saccharinum Natricum | | | | Simeticone | | | | Sorbitani Lauras | | | | Xanthani Gummi | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 023 | 10 ml | 3.08 | 7.65 | B | | Oui |
|
|
